Psychometric Validation of a French-language Version of the PERMA-Profiler: Tools for Assessing Multidimensional Subjective Well-being
Launched by CENTRE HOSPITALIER UNIVERSITAIRE DE NĪMES · Jun 26, 2023
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a tool called the PERMA-Profiler, which is designed to help measure a person's overall well-being. The researchers want to make sure that the French version of this tool is accurate and reliable by comparing it to a well-established questionnaire. The goal is to understand how well this tool can assess different aspects of happiness and life satisfaction in people living in France, particularly those dealing with psychiatric disorders.
To be eligible for the study, participants need to be adults aged 18 and older who can read and understand French. It’s important that they are willing to take part in the study. However, people who have had a serious brain injury or cannot understand French will not be able to participate. If someone joins the study, they can expect to fill out the questionnaire and help researchers learn more about how to measure well-being effectively. This information could be valuable for improving mental health support in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adult (≥18 years).
- • Person able to read and understand French
- • Person willing to participate in this study
- Exclusion Criteria:
- • The person does not understand the French language
- • Person has a history of traumatic brain injury
- • The person refuses to participate in the study
About Centre Hospitalier Universitaire De Nīmes
The Centre Hospitalier Universitaire de Nîmes (CHU Nîmes) is a leading academic medical center located in Nîmes, France, dedicated to advancing healthcare through innovative clinical research and patient care. As a prominent sponsor of clinical trials, CHU Nîmes collaborates with a multidisciplinary team of healthcare professionals and researchers to conduct rigorous studies aimed at improving treatment outcomes and enhancing medical knowledge across various specialties. With a strong commitment to ethical standards and patient safety, CHU Nîmes fosters a research environment that encourages scientific excellence and contributes to the development of new therapies and healthcare solutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Nimes, , France
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported